The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Autor: | Haiyun Yu, Fei Guan, Heather Miller, Jiahui Lei, Chaohong Liu |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Emerging Microbes and Infections, Vol 12, Iss 1 (2023) |
Druh dokumentu: | article |
ISSN: | 22221751 2222-1751 |
DOI: | 10.1080/22221751.2022.2164219 |
Popis: | ABSTRACTThe coronavirus disease 2019 (COVID-19) has caused enormous health risks and global economic disruption. This disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 nucleocapsid protein is a structural protein involved in viral replication and assembly. There is accumulating evidence indicating that the nucleocapsid protein is multi-functional, playing a key role in the pathogenesis of COVID-19 and antiviral immunity against SARS-CoV-2. Here, we summarize its potential application in the prevention of COVID-19, which is based on its role in inflammation, cell death, antiviral innate immunity, and antiviral adaptive immunity. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |